Quilalong, Vance Tyrell P.
HRN: 25-78-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CEFTRIAXONE 1G (VIAL)
09/02/2024
09/09/2024
IV
1.7g
Q24hours
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes